American Century Companies’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

American Century Companies's PSTX Position: Q1 2025 in Review

American Century Companies sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 42,073 shares — an estimated $404K sold.

American Century Companies first reported a position in PSTX in Q1 2023 and held it in 8 quarters. The position peaked at $404K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

• American Century Companies reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
• American Century Companies sold 42,073 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $404K.
• American Century Companies first reported a position in Poseida Therapeutics, Inc. Common Stock in Q1 2023 and held it in 8 quarters.
• American Century Companies's Poseida Therapeutics, Inc. Common Stock position peaked at $404K in Q4 2024.
• 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on American Century Companies's 13F filing for Q1 2025, filed 13 May 2025.